Sign In

News Story

US Senate releases appropriations proposal

Includes $2 billion funding increase for NIH in FY 2023.

On July 28, the U.S. Senate Appropriations Committee released its FY 2023 spending bill that includes a $2 billion funding increase for the National Institutes of Health (NIH), including a $291 million funding boost for the National Cancer Institute (NCI). 

The bill also includes $1 billion for the Advanced Research Projects Agency on Health (ARPA-H) to help accelerate new innovations in treatments for cancer and other diseases. Additionally, the bill allocates $31 million in additional funding for the Centers for Disease Control and Prevention’s (CDC) Division of Cancer Prevention and Control (DCPC), including a $10 million increase for the National Breast and Cervical Cancer Early Detection Program to provide breast and cervical cancer screening for uninsured and underinsured individuals, and a $20 million increase for the CDC’s Office on Smoking and Health for programs that help prevent youth from starting to use tobacco and helps adult tobacco users to quit.

According to recent data, grant applications to NCI have increased by more than 50% compared to just over 5% of other Institutes. The House-passed version of the Labor, Health and Human Services, and Education funding legislation increases NCI funding by $466 million, far more than the $291 million increase the Senate Appropriations Committee included in today’s bill. 

American Cancer Society Cancer Action Network (ACS CAN) President Lisa Lacasse released a statement in support of the proposed funding increase, and believes it is an important step toward ensuring continued progress is made in developing improved ways to prevent, detect and treat cancer.

“Federal funding for cancer research has clearly demonstrated its worth and we appreciate lawmakers’ ongoing commitment to investing in advancing new therapies and providing hope to the nearly 2 million Americans expected to be diagnosed with cancer this year,” said Lacasse. “We urge the Senate and House to consider the nation’s robust research and prevention needs and allocate maximum medical research funding as they move ahead in this process, and we look forward to working with them on a final appropriations agreement.”

See the full press statement for further details and ACS CAN’s response on the bill.


back to top